Form 4 for NEO NEOGENOMICS INC
Accepted 2022-06-02 00:00:00 ET · period of report 2022-06-01 · accession 0001077183-22-000091 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-02 | 2022-06-01 | NEO | Sikri Vishal | Pres, CCO, Inivata | A - Grant | $0.00 | +148.5K | 148.5K | New | $0 |
| D | 2022-06-02 | 2022-06-01 | NEO | Sikri Vishal | Pres, CCO, Inivata | A - Grant | $0.00 | +319.1K | 319.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-01 | A | A | 148,455 | $0.00 | 148,455 | D | — | — | (F2) On June 1, 2022, Mr. Sikri was granted 59,382 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date. (F1) On June 1, 2022, Mr. Sikri was granted 89,073 restricted stock awards. These awards vest ratably over the first two anniversary dates of the grant date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-01 | A | A | 319,112 | $0.00 | 319,112 | D | $8.42 · — to 2029-06-01 | 319,112 Common Stock | (F4) On June 1, 2022, Mr. Sikri was granted 125,313 stock options. These options vest ratably over the first four anniversary dates of the grant date. (F3) On June 1, 2022, Mr. Sikri was granted 193,799 stock options. These options vest ratably over the first two anniversary dates of the grant date. |